1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 290 F.Supp.3d
  5. 290 F.Supp.3d 65 (2018)
 

AMGEN INC. v. AZAR

Civil Action No. 17-1006 (RDM).

290 F.Supp.3d 65 (2018)

AMGEN INC., Plaintiff, v. Alex AZAR II, Secretary, U.S. Department of Health and Human Services, et al., Defendants, and Amneal Pharmaceuticals, LLC, Intervenor-Defendant.

United States District Court, District of Columbia.

Signed February 17, 2018.

Editors Note
Applicable Law: 05 U.S.C. § 0706
Cause: 05 U.S.C. § 0706 Judicial Review of Agency Actions
Nature of Suit: 890 Other Statutory Actions
Source: PACER

Attorney(s) appearing for the Case

Catherine Emily Stetson, Susan Margaret Cook, Hogan Lovells US LLP, Washington, DC, for Plaintiff.

Charles John Biro, U.S. Department of Justice, Washington, DC, for Defendants.

Douglas B. Farquhar, Jennifer McVey Thomas, Kurt R. Karst, Hyman, Phelps & McNamara, P.C., Washington, DC, for Intervenor-Defendant.

MEMORANDUM OPINION

Amgen brought this action to challenge the decision of the Food and Drug Administration ("FDA") denying Amgen pediatric exclusivity for its drug, Sensipar (cinacalcet hydrochloride). In an earlier opinion and order, the Court granted the FDA summary...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases